Exane Derivatives’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.22K | Hold |
20
| – | – | ﹤0.01% | 486 |
|
|
2022
Q1 | $1.26K | Hold |
20
| – | – | ﹤0.01% | 786 |
|
|
2021
Q4 | $1.52K | Sell |
20
-900
| -98% | -$68.2K | ﹤0.01% | 670 |
|
|
2021
Q3 | $103K | Buy |
920
+270
| +42% | +$30.2K | 0.02% | 507 |
|
|
2021
Q2 | $88.1K | Sell |
650
-13
| -2% | -$1.76K | 0.02% | 548 |
|
|
2021
Q1 | $80.8K | Buy |
+663
| New | +$80.8K | 0.02% | 440 |
|